Protein tyrosine phosphatase (PTP)σ (PTPRS) was shown previously to be associated with susceptibility to inflammatory bowel disease (IBD). PTPσ −/− mice exhibit an IBD-like phenotype in the intestine and show increased susceptibility to acute models of murine colitis. However, the function of PTPσ in the intestine is uncharacterized. Here, we show an intestinal epithelial barrier defect in the PTPσ −/− mouse, demonstrated by a decrease in transepithelial resistance and a leaky intestinal epithelium that was determined by in vivo tracer analysis. Increased tyrosine phosphorylation was observed at the plasma membrane of epithelial cells lining the crypts of the small bowel and colon of the PTPσ −/− mouse, suggesting the presence of PTPσ substrates in these regions. Using mass spectrometry, we identified several putative PTPσ intestinal substrates that were hyper-tyrosine-phosphorylated in the PTPσ −/− mice relative to wild type. Among these were proteins that form or regulate the apical junction complex, including ezrin. We show that ezrin binds to and is dephosphorylated by PTPσ in vitro, suggesting it is a direct PTPσ substrate, and identified ezrin-Y353/Y145 as important sites targeted by PTPσ. Moreover, subcellular localization of the ezrin phosphomimetic Y353E or Y145 mutants were disrupted in colonic Caco-2 cells, similar to ezrin mislocalization in the colon of PTPσ −/− mice following induction of colitis. Our results suggest that PTPσ is a positive regulator of intestinal epithelial barrier, which mediates its effects by modulating epithelial cell adhesion through targeting of apical junction complex-associated proteins (including ezrin), a process impaired in IBD.
mouse, suggesting the presence of PTPσ substrates in these regions. Using mass spectrometry, we identified several putative PTPσ intestinal substrates that were hyper-tyrosine-phosphorylated in the PTPσ −/− mice relative to wild type. Among these were proteins that form or regulate the apical junction complex, including ezrin. We show that ezrin binds to and is dephosphorylated by PTPσ in vitro, suggesting it is a direct PTPσ substrate, and identified ezrin-Y353/Y145 as important sites targeted by PTPσ. Moreover, subcellular localization of the ezrin phosphomimetic Y353E or Y145 mutants were disrupted in colonic Caco-2 cells, similar to ezrin mislocalization in the colon of PTPσ −/− mice following induction of colitis. Our results suggest that PTPσ is a positive regulator of intestinal epithelial barrier, which mediates its effects by modulating epithelial cell adhesion through targeting of apical junction complex-associated proteins (including ezrin), a process impaired in IBD. P rotein tyrosine phosphatase (PTP)σ, encoded by PTPRS (1), consists of a cell adhesion molecule-like ectodomain containing three immunoglobulin (Ig)-like and three to eight fibronectin type III repeats, a transmembrane domain, and a cytosolic region with two PTPase domains, of which the first (D1) is catalytically active (2) . PTPσ expression is developmentally regulated and found primarily in the nervous system and specific epithelia (3, 4) . It was previously shown to play a role in axon growth and path finding (5-7), neuroregeneration (5, 8, 9) , autophagy (10) , and neuroendocrine development (11) (12) (13) .
To investigate the function of PTPσ in vivo, our group (11) and Tremblay and coworkers (12) generated PTPσ −/− mice. These mice exhibited high neonatal mortality, various neurological and neuroendocrine defects, colitis, and cachexia (5, 11, 13, 14) . Analysis of the intestinal tissue in surviving mice by our group revealed the presence of mucosal inflammation, intestinal crypt branching, and villus blunting: all features of colitis similar to the enteropathy associated with human inflammatory bowel disease (IBD) (15) . Notably, PTPσ −/− mice also showed increased susceptibility to chemical and infectious models of murine colitis, specifically treatment with dextran sodium sulfate (DSS) or infection with Citrobacter rodentium (15) . The intestinal phenotype in the mice strongly inferred a connection between PTPσ and IBD.
IBD is a chronic, idiopathic, relapsing disorder affecting the gastrointestinal tract, where Crohn disease and ulcerative colitis (UC) are the two major forms (16) . In IBD pathogenesis, the presence of environmental factors together with polymorphisms in IBD-susceptibility genes cause an abnormal innate and adaptive host immune response to commensal gut bacteria, leading to sustained and deleterious inflammation (17) . Chronic infection (18, 19) , dysbiosis (19) , defective mucosal barrier defense (20) , and insufficient microbial clearance (19) have all been implicated as factors contributing to IBD pathogenesis. The disease is known to have a strong genetic component, as evidenced by specific populations exhibiting a disproportionately high incidence (21) and the high disease concordance between monozygotic twins (22) . Genome-wide association studies and associated metaanalyses have implicated several genes and pathways in IBD, notably genes associated with intestinal barrier defense [MYO9B (23) , PARD3 (24), MAGI2 (24), CDH1 (25, 26) ].
Through SNP analysis of IBD patients, we showed that PTPRS is genetically associated with UC (15) . The identified SNP polymorphism leads to alternative splicing in the extracellular region of the epithelial isoform of PTPσ, causing loss of the third Ig domain (15) . This splicing might potentially lead to altered ligand recognition or may affect receptor dimerization (27) . In addition, through an interaction-trap assay, we identified the apical junction complex (AJC) proteins E-cadherin (CDH1) and β-catenin (CTNNB1) as colonic substrates of PTPσ (15) . Interestingly, recent large-scale genetic studies have identified over 160 loci that affect risk of developing IBD, many of which involved in barrier regulation (24, 28, 29) .
The AJC confers polarity to epithelial cells and maintains intestinal barrier integrity (30) . Defective regulation of AJC proteins creates disrupted epithelial barriers, permeability defects, and aberrant intestinal morphology (30, 31) , similar to defects seen in IBD. The connection between the AJC and IBD is further Significance Polymorphisms in the protein tyrosine phosphatase (PTP)σ (PTPRS) gene were previously shown to be associated with inflammatory bowel disease (IBD), and PTPσ knockout mice exhibit an intestinal IBD phenotype, but how PTPσ is involved in IBD is unknown. Our studies here show that PTPσ knockout mice exhibit a leaky intestinal epithelium that may explain the observed IBD phenotype. We further identify the junctional protein ezrin as an in vivo intestinal substrate for PTPσ and identify specific tyrosine phosphorylation sites on ezrin that are targeted by PTPσ, leading to removal of ezrin from its plasma membrane localization. These studies help explain the role of PTPσ in IBD.
demonstrated by our earlier SNP analysis, which revealed a haplotype polymorphism in CDH1 that is associated with Crohn disease, leading to a truncated E-cadherin protein that fails to localize to the plasma membrane (PM), as also observed in IBD patient biopsy samples (25) . Thus, we postulate that PTPσ regulates epithelial barrier integrity through regulation of AJC proteins and that defective PTPσ function may contribute to IBD.
In this report, we demonstrate an intestinal epithelial barrier defect in the PTPσ −/− mice and identify the AJC protein ezrin as an in vivo colonic substrate for PTPσ. We further demonstrate that dephosphorylation of ezrin-Y353 or -Y145 by PTPσ leads to its redistribution from the PM to the cytosol, similar to its localization following induction of IBD in mice.
Results

PTPσ
−/− Mice Exhibit Defects in Intestinal Barrier Integrity. Given the importance of the adherens junction in epithelial cell adhesion and barrier defense, we investigated the integrity of the intestinal epithelial layer in our PTPσ −/− mice by evaluating the permeability and electrophysiology of the small bowel and colon ex vivo and performing in vivo tracer studies. Small bowel and colon sections from PTPσ +/+ and PTPσ −/− mice were analyzed in an Ussing Chamber. PTPσ −/− mouse colon and small bowel both showed a significant decrease in transepithelial electrical resistance (TEER) (Fig. 1A ) and increased macromolecular flux (Fig. 1B ) compared with PTPσ +/+ littermates. PTPσ +/− mice were similar to wild-type (WT) controls. These data suggest that loss of PTPσ function leads to loss of epithelial resistance, indicating a potential defect in intestinal permeability. To confirm these observations in vivo, mice were gavaged with fluorescein isothiocyanate (FITC)-conjugated dextran that acts as a molecular probe to evaluate epithelial barrier permeability. Two different size dextran conjugates were used, 4.4 kDa and 40 kDa, to assess both paracellular and macromolecular permeability, respectively. PTPσ −/− mouse small bowel and colon tissue showed increased FITC serum levels for both dextran conjugates compared with PTPσ +/+ littermates ( Fig. 1 C and D) . PTPσ +/− mouse tissue showed slightly elevated levels but were not significantly different from their PTPσ +/+ littermates. These data support the Ussing chamber results and further suggest a role for PTPσ in the maintenance of epithelial barrier integrity.
PTPRS Is Expressed in the Crypts Regions of Mouse Intestine. The gene-inactivating cassette used to generate our PTPσ −/− mice contains a β-galactosidase reporter, which is thus expressed from the endogenous PTPRS promoter (11) . To determine where PTPRS (PTPσ) is expressed in the intestine, we performed X-gal staining on frozen tissue sections from PTPσ +/− mice. Dark blue/ black staining indicative of PTPσ expression was observed in the epithelial cells lining the crypt region of the small bowel and colon in the heterozygous mice that was not present in the WT (Fig. 2) . In the small bowel, PTPσ expression appeared most prominent at the base of the crypts (Fig. 2C) , an area of rapid cell proliferation. In addition, we also observed PTPσ expression in cells present in the lamina propria regions of the small bowel and colon ( Fig. 2 B and E) , including macrophages and lymphocytes (Fig. S1 ).
Enriched Tyr Phosphorylation in the Crypts of PTPσ
−/− Mouse Colon and Small Bowel. To determine how loss of PTPσ regulation affects Tyr phosphorylation in the intestine, we investigated the localization and extent of Tyr phosphorylation in PTPσ −/− and PTPσ +/+ mouse colon and small bowel using immunofluorescence microscopy. Colon and small bowel sections from both untreated and DSS-treated PTPσ +/+ and PTPσ −/− mice were immunostained using anti-phosphotyrosine (pTyr) antibody (Fig. 3) . In the untreated mice, the villi in the small bowel did not show significant pTyr staining in either the PTPσ +/+ or PTPσ sections. In contrast, the crypt regions of the PTPσ −/− small bowel showed strong pTyr staining compared with PTPσ +/+ controls (Fig.  3A) . A similar crypt staining pattern was also observed in the colon of PTPσ −/− mice (Fig. 3B) . Interestingly, this Tyr phosphorylation pattern colocalized with the AJC marker E-cadherin (Fig. S2 ). In addition, cells in the lamina propria along the crypt-villus axis showed increased Tyr phosphorylation in the PTPσ −/− mice (Fig. 3A) . These results support the X-gal staining (Fig. 2) , because the increase in Tyr phosphorylation is located in regions positive for PTPσ expression.
In the DSS-treated mice, pTyr staining was enriched in all genotypes in both the small bowel (Fig. 3C ) and colon (Fig. 3D) , with further increase in the PTPσ −/− mice relative to DSS-treated control littermates.
Identification of Ezrin and Villin as Binding Partners for PTPσ. The increased permeability and Tyr phosphorylation in the PTPσ −/− mouse intestine suggest that PTPσ is regulating proteins associated with maintenance of the epithelial barrier. To identify the intestinal substrates of PTPσ that may regulate intestinal barrier integrity, we performed mass spectrometry (MS) on colon homogenates from PTPσ −/− and PTPσ +/+ mice following immunoprecipitation (IP) with anti-pTyr antibodies and trypsin digestion, to identify hyper-Tyr-phosphorylated proteins in the knockout (KO) colons. Table S1 reveals 37 proteins enriched in Tyr phosphorylation in the PTPσ −/− colon relative to WT, with some of them (e.g., E-Cadherin, β-catenin, p130CAS, EGFR) already identified earlier as PTPσ substrates (15, 32, 33) . Among the new putative substrates, we noticed numerous AJC proteins, including ezrin and villin (Table S1 ). Ezrin is implicated in the organization of the apical web region and participates in several signaling pathways including adherens junction remodeling (34, 35) , and Ezr −/− mice have defects in intestinal epithelial architecture (31) . Villin regulates actin filaments, cell morphology, and microvilli formation (36) , and loss of villin increases colonic susceptibility to the DSS model of murine colitis (36) .
To confirm the MS data, an in vitro substrate-trapping assay was performed using GST-fusion proteins that contain the catalytically active D1 domain of PTPσ or its inactive, substratetrapping PTPσD1(D1472A) mutant (14) . Fig. 4 A and B shows that ezrin and villin can bind to the D1 domain of PTPσ but not to GST alone.
Ezrin Is a Substrate of PTPσ. To test whether ezrin and villin are substrates of PTPσ, an in vitro dephosphorylation assay was performed. GST-fusion proteins containing the intracellular PTPase domains of PTPσ were purified, and their phosphatase activity was determined by incubation with para-nitrophenyl phosphate (pNPP), a generic pTyr substrate (Fig. 4C ). Only fusion proteins containing the active D1 domain (PTPσD1 and PTPσD1D2) showed PTPase activity. The PTPσD1(D1472A) mutant showed no activity, as expected. To test for dephosphorylation of ezrin in cell lysate, purified GST-tagged PTPσD1, PTPσD1D2, or the inactive PTPσD2 and PTPσD1 (D1472A) were incubated with immunoprecipitated FLAGezrin and immunoblotted for anti-pTyr. Tyr phosphorylation has been implicated in ezrin trafficking to the PM (37, 38) . In accordance, we found that treatment of cells with pervanadate led to accumulation of ezrin at the PM (Fig. 5A ), suggesting that its Tyr phosphorylation is required for this PM localization.
Phosphorylation of tyrosines Y145, Y191, Y353, and Y477 in ezrin was previously described and has been implicated in a range of processes, including cellular adhesion (35) and cytoskeletal remodeling (39) . Thus, we mutated each of these tyrosines to either Phe or the phosphomimetic Glu, transfected them into colonic Caco-2 cells, and followed ezrin distribution by confocal microscopy. As seen in Fig. 5A and quantified in Fig.  5B , there was a significant redistribution of two ezrin mutations (Y145 and Y353E) from the cytoplasm to the cell periphery relative to the Y145F or Y353F mutant, respectively. The other mutants did not exhibit altered distribution. MS analysis of pervanadate-pretreated ezrin following incubation with the active domain of PTPσ revealed decreased abundance of phosphopeptides containing pY353, indicative of tyrosine phosphatase activity directed toward this site ( Fig. 5 C and D) . Moreover, the relative distribution of Tyr-phosphorylated peptides determined by our MS analysis of the PTPσ KO colons demonstrated greater phosphorylation of Y145 and Y353 relative to other pTyr sites (Fig. S4 ). These results suggest that Y353 and Y145 are likely important tyrosines that are normally dephosphorylated by PTPσ, leading to redistribution of ezrin in the cell. This dephosphorylation-dependent cytoplasmic redistribution is likely not mediated by E-cadherin since although ezrin can (weakly) bind E-cadherin, this interaction is diminished, not increased, in the ezrin-Y353E mutant (Fig. S5) .
To complement the ezrin localization experiments, we performed immunofluorescence analysis on mouse tissue sections from our PTPσ −/− and PTPσ +/+ mice. Small bowel and colonic tissue was acquired from both naïve and DSS-treated PTPσ and PTPσ +/+ mice. Ezrin localization in naïve mouse colon and small bowel revealed no difference between PTPσ −/− and PTPσ +/+ sections (Fig. 6A) . However, differences in ezrin localization were observed between PTPσ −/− and PTPσ +/+ small bowel sections after DSS treatment (Fig. 6B) . The PTPσ +/+ small bowel tissue showed ezrin localization in both the cytoplasm and at the PM, in contrast to the PTPσ −/− tissue, which showed PM staining almost exclusively (and in line with our observations in Fig. 5 ). This suggests that PTPσ may regulate ezrin trafficking and that loss of PTPσ leads to accumulation of ezrin at the PM under acute inflammatory conditions.
Discussion
We demonstrate here a defect in intestinal barrier integrity of the PTPσ −/− mice, suggesting destabilized epithelial monolayer that forms the barrier between the intestinal lumen and lamina propria. Cell adhesion, mediated by the AJC, is essential to barrier function of polarized epithelia (30) . Interestingly, our MS analysis identified numerous hyper-Tyr-phosphorylated proteins in the PTPσ −/− mouse intestine with functions associated with the AJC. These hits include proteins that mediate intercellular junctioning (E-cadherin, β-catenin, Tjp-2), proteins that regulate interactions with the actin cytoskeleton (villin, ezrin, gelsolin), and proteins that regulate signaling pathways that modulate junction complex formation and remodeling (EGFR, ezrin). We postulate that PTPσ functions as a positive regulator of epithelial barrier integrity in the intestine through the regulation of 
Absorbance at 405nm proteins associated with the AJC, including ezrin. Although E-cadherin and β-catenin form the essential core of the adherens junction, and we previously demonstrated these proteins to be colonic PTPσ substrates (15), we believe that PTPσ-mediated regulation of ezrin is another mode in which this PTP regulates the AJC, likely independent of E-cadherin (Fig. S5) . We demonstrate that ezrin is a direct intestinal substrate of PTPσ and that its cellular localization is altered by Tyr dephosphorylation of ezrin-Y353/Y145 by PTPσ, indicating that Tyr phosphorylation of ezrin, especially at Y353 or Y145, is required to localize/maintain it at the PM. Interestingly, DSS treatment, used to induce colitis, augments the PM localization of ezrin in the PTPσ −/− mice, suggesting that DSS or colitis may increase Tyr phosphorylation of ezrin, leading to its increased retention (or arrival) at the PM. The presence of this mislocalization mainly during DSS-treatment does suggest that other PTPs are likely also involved in the regulation of ezrin trafficking, given that we still observe ezrin at the PM in the untreated mice. How Tyr phosphorylation of ezrin regulates its cellular localization in not known, but its phosphorylation is essential for its function as a scaffold protein. In accordance, several binding partners of ezrin, including Src [which phosphorylates Y145 and Y477 (40) ] and p85 [the regulatory subunit of PI3K, which is recruited to pY353 (41)], bind to it through SH2 domain-mediated interactions. PTPσ could potentially regulate the ezrin-mediated activation of these effectors by targeting pTyr residues that serve as SH2-binding sites. Interestingly, several of the signaling pathways regulated by ezrin are important for cell adhesion. Rac1 is a potent regulator of actin cytoskeletal dynamics and was shown to regulate adherens junction assembly through E-cadherin (35) . In addition, Src is a known mediator of cell adhesion and adherens junction remodeling (40) .
In the context of IBD pathogenesis, it is possible that the defective barrier integrity observed the PTPσ −/− mouse intestine may contribute to the development of intestinal enteropathies by increasing the exposure of the lamina propria to luminal pathogens. A "leaky" intestinal epithelium has been previously implicated in IBD (30) and barrier defects have been observed in IBD patients (42) , but the underlying genetic basis for these effects were not well characterized. Our work presented here suggests a new function for PTPσ as a positive regulator of epithelial barrier integrity, which may help explain the underlying genetic risk in IBD associated with defects in permeability. Our current work, however, cannot preclude the possibility that cells in the lamina propria (such as macrophages or lymphocytes), which express PTPσ, also contribute to the intestinal pathogenesis we observe in the PTPσ −/− mice.
Materials and Methods
Generation of Constructs and pTyr Mutants. FLAG epitope-tagged full-length ezrin-and villin-fusion constructs were generated as described in SI Materials and Methods. Site-directed mutagenesis was performed to generate phosphomimetic (Y→E) and phosphoablated (Y→F) ezrin mutants at sites Y145, Y191, Y353, and Y477 (Table S2) .
Tandem Immunoprecipitation of pTyr-MS. pTyr-containing proteins were isolated from PTPσ −/− and WT littermate intestinal tissue homogenates by IP, digested with trypsin to generate peptide fragments, and characterized through tandem MS as outlined in SI Materials and Methods. Identified proteins were ranked according to the difference in unique spectral counts between the PTPσ +/+ and PTPσ −/− mice.
In Vitro Substrate-Trapping and Dephosphorylation Assays. GST-fusion proteins containing the intracellular PTPase domains of PTPσ (14), including a substrate-trapping D1472A mutant, were used to immunoprecipitate FLAG-tagged ezrin-and villin-fusion proteins as described in SI Materials and Methods. Dephosphorylation assays were performed in vitro using these GST-fusion proteins.
Ussing Chamber Studies. PTPσ
, and WT littermates were killed by cervical dislocation; small bowel (proximal to cecum) and colonic (proximal to rectum) sections were excised and mounted in an Ussing chamber as detailed in SI Materials and Methods. Macromolecular flux was assessed by the addition of unconjugated horseradish peroxidase (HRP) to the luminal chamber as described (43) . , and WT littermates were orogastrically gavaged with FITC-dextran (4 and 40 kDa). After 4 h, mice were killed by cervical dislocation, blood was extracted by cardiac puncture and then separated by centrifugation, and serum levels of FITC were analyzed by fluorimetry as detailed in SI Materials and Methods.
Immunohistochemistry. Small bowel and colonic tissue from PTPσ
−/− mice and WT littermates were embedded in paraffin, sectioned (5 μm), processed, and immunostained with anti-E-cadherin, anti-β-catenin, and anti-ezrin antibodies as described in SI Materials and Methods. Immunofluorescence Microscopy on Caco-2 Monolayers. Caco-2 BBe cells were transiently transfected in suspension with FLAG-tagged WT or pTyr mutant ezrin. Transfected cells were seeded onto Transwell permeable supports and grown for 4 d as outlined in SI Materials and Methods. Membranes containing cell monolayers were mounted on glass slides for immunofluorescence microscopy using anti-FLAG antibodies and Alexa Fluor 488-conjugated phalloidin.
Identification of pTyr Sites by MS. WT FLAG-ezrin was transiently transfected in HEK293T cells. Following pervandate treatment to enrich for Tyr phosphorylation, ezrin was immunoprecipitated and incubated with the D1 domain of PTPσ for various time points as described in SI Materials and Methods. The bound FLAG-ezrin was digested with trypsin, and the resulting pTyr-containing peptide fragments were isolated by IP then analyzed by MS (as above). mice were generated and backcrossed onto a pure C57BL/6 background as described previously (1) . Mice used for experiments were between 8-to 12-wk-old and all control mice were littermates of the PTPσ −/− mice. Mice were housed in a specific-pathogen free environment with a standard diet and free access to water. Animal care and experimental protocols were approved by the Animal Care Committee at the Hospital for Sick Children.
Supporting Information
Constructs. Full-length human ezrin cDNA was obtained via SIDNET (Hospital for Sick Children) from the Mammalian Gene Collection on a pOTB7 plasmid. This cDNA was cloned into the N-terminal FLAG epitope-tagged mammalian expression plasmid, pcDNA 3.1/nFLAG, using the Gateway system (Invitrogen). Site-directed mutagenesis was performed using the Quikchange II system (Invitrogen) to generate phosphotyrosine (pTyr) ezrin mutants (Y to F or Y to E) at sites Y145, Y191, Y353, and Y477 as outlined in Table S2 . Two double mutants, ezrin-Y145F/Y145F and ezrin-Y145E/Y353E, were also generated. All point mutations were confirmed by DNA sequencing.
GST-fusion constructs for the intracellular PTPase domains of rat PTPσ [GST-PTPσ-D1, GST-PTPσ-D1D2, GST-PTPσ-D2, GST-PTPσ-D1(D1478A)] were previously generated in a bacterial expression plasmid, pGEX-2T, as described (2). The tissue was homogenized using a handheld rotor-stator homogenizer set to medium intensity and left on ice for 30 min. The resulting slurry was centrifuged at 12,500 × g at 4°C for 30 min, and the supernatant was clarified through a 0.45-μm filter.
Tandem Immunoprecipitation of pTyr-Mass Spectrometry. Mouse colon tissue homogenate was incubated overnight at 4°C with a commercial pTyr immunoprecipitation (IP) kit (Sigma) with anti-pTyr-agarose. The beads were washed twice with IP wash buffer [20 mM Hepes (pH 7.5), 10% glycerol, 0.1% Triton X-100, and 150 mM NaCl] and twice with HPLC-grade water. The bound proteins were eluted using 0.1% trifluoroacetic acid. Eluted proteins were digested with trypsin and desalted, and the resultant peptide mixtures were separated on an automated nanoliter-scale liquid chromatography system (Easy-nLC; Proxeon Biosystems) and then detected using a Thermo-Fisher linear ion trap mass spectrometer system (LTQ), to identify pTyrcontaining fragments, as described (3). Over 3,600 unique spectral hits were identified in each of the tissues. To refine this list to isolate potential PTPσ substrates, spectral hit counts were compared between PTPσ −/− and PTPσ +/+ samples (because we demonstrated by immunofluorescence that loss of PTPσ leads to an increase in Tyr phosphorylation in the intestine; Fig. 3 ). Proteins were ranked according to the difference in unique spectral counts between samples and a minimum threshold of four was assigned to select specifically for phosphoproteins enriched in the PTPσ −/− mouse tissue.
In Vitro Substrate-Trapping Assay. Tissue homogenate from PTPσ −/− mouse colon and small bowel was obtained as above. DH5α Escherichia coli transformed with the GST-fusion proteins was grown in 1 L of Lennox broth at 37°C to an OD 590 of 0.7, followed by addition of 1 mM IPTG to induce expression. After 2 h of induction, the cells were collected by centrifugation, resuspended in PBS supplemented with protease inhibitors (as above) and 1 mM lysozyme, and lysed by sonication. After clarification by centrifugation at 12,500 × g for 30 min at 4°C, the GST-fusion proteins were purified through incubation 200 μL of GST-agarose (Sigma) for 1 h. To perform the substrate trapping, 5 mg of PTPσ −/− mice colonic tissue homogenate in 1 mL of lysis buffer was incubated with 20 μL of the GST-agarose bound to the GST-fusion proteins. Bound proteins were washed twice with lysis buffer and then twice with low-salt HNTG buffer [20 mM Hepes, 150 mM NaCl, 0.1% Triton X-100, 10% (vol/vol) glycerol]. The beads were compacted by centrifugation, the supernatant was aspirated, and 30 μL of 1× SDS sample buffer was added. Following a brief incubation at 95°C, the proteins were separated using SDS/PAGE and transferred to a nitrocellulose membrane (GE Healthcare) for immunoblotting.
The antibodies used for immunoblotting were as follows: mouse anti-ezrin (1:1,000; 3C12; Invitrogen), mouse anti-villin (1:1,000; BD Biosciences), mouse anti-pTyr (1:1,000; 3G10; Invitrogen), mouse anti-E-cadherin (1:1,000; BD Biosciences), and mouse anti-p130cas (1:1,000; BD Biosciences). Following a 1 h of incubation with primary antibody, the blots were incubated with horseradish-peroxidase (HRP)-conjugated goat anti-mouse secondary antibody (1:10,000; Covance) in PBSTween 20 and developed with Western Lightning Plus ECL (Perkin-Elmer).
Tissue Culture. Human embryonic kidney (HEK)-293T cells were maintained in Dulbecco's minimum essential minimum (DMEM) supplemented with 10% FBS and 1% penicillin/streptomycin at 37°C and 5% CO 2 ; 20 μg of DNA for each of the FLAG-tagged plasmids was transiently expressed using the calcium phosphatetransfection method onto 100-mm dishes. After 2 d, cells were treated for 10 min with 40 μL of sodium pervanadate prepared by adding equal volumes 1 mM sodium orthovanadate and 1% hydrogen peroxide, to enrich for Tyr-phosphorylated proteins. Cells were lysed using 1 mL of lysis buffer supplemented with protease inhibitors (as above).
Localization Experiments in Caco-2 Cells. Caco-2 BBe colorectal adenocarcinoma (C2BBe1; American Type Culture Collection CRL-2102) cells were maintained in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, and 10 μg/mL transferrin (Gibco, Invitrogen) at 37°C and 5% CO 2 ; 3 × 10 6 cells were transiently transfected in suspension with FLAG epitope-tagged wild-type (WT) and pTyr ezrin mutants using PolyJet transfection reagent (Signagene Laboratories) and seeded onto 6.5-mm Transwell permeable supports with 3.0-μm pore size (Costar 3145; Corning) in 24-well tissue culture plates. Cells were grown for 4 d in complete media then fixed in 4% paraformaldehyde (PFA) in PBS. Inserts were removed with a scalpel and placed on microscope slides for immunofluorescence microscopy. Cells were immunostained with anti-FLAG antibody (2 μg/mL; M2; Sigma), followed by Alexa Fluor 568 goat anti-mouse IgG (4 μg/mL; Invitrogen) and Alexa Fluor 488 phalloidin (Invitrogen) antibodies. Imaging analysis was performed on an Olympus IX81 inverted fluorescence microscope equipped with a Hamamatsu C9100-13 back-thinned EM-CCD camera and Yokogawa CSU ×1 spinning disk confocal scan head.
para-Nitrophenyl Phosphate Phosphatase-Activity Assay. GST-fusion proteins were purified as above. Thirty microliters of the GSTagarose bound to the GST-fusion proteins were added to 300 μL of PBS with 1 mg/mL para-nitrophenyl phosphate (pNPP) (Sigma) in a 96-well plate. The plate was incubated at 37°C for 30 min, and then the absorbance was read at 405 nm. Absorbance readings were normalized to zero values taken at start of incubation. Readings displayed on Fig. 2A are at the 30-min time point.
In Vitro Dephosphorylation Assay. Activity of GST-fusion proteins was confirmed using the pNPP assay above. FLAG-tagged proteins were precipitated from cell lysate using 20 μL of Anti-M2 FLAG-agarose (Sigma) for 1 h at 4°C. Bound proteins were washed twice with lysis buffer and twice with low-salt HNTG. The GST-and FLAG-fusion proteins were eluted from the beads using 50 mM Tris·HCl (pH 8.0) with 10 mM reduced glutathione and 0.1 M glycine (pH 3.5) quenched with 10% vol/ vol 100 mM Tris·HCl (pH 8.0), respectively. Fifty microliters of each of the eluted GST-fusion proteins and the eluted FLAGfusion proteins were combined in 50 μL of PBS and incubated for 30 min at 37°C. The reaction was stopped by the addition of 30 μL of 5× SDS sample buffer. To inhibit the activity of the phosphatase domain, pervandate (PV) was included with the incubation (Fig. S3 ). Proteins were separated on SDS/PAGE gel and immunoblotted as described above. To conduct mass spectrometry (MS) analysis to determine pTyr targets of PTPσ on ezrin, the dephosphorylation experiment was repeated without eluting the FLAG-tagged proteins from the beads. Following the incubation, these beads were washed and then processed for tandem MS as described above. To enrich for pTyr-containing tryptic peptide fragments, a pTyr IP kit (PScan no. 7902-S; Cell Signaling Technology) was used before tandem MS analysis.
Immunohistochemistry. Fixed intestinal tissue sections were dissected to isolate regions of interest then embedded in paraffin. Five-micron sections were obtained using a microtome and placed on Superfrost Plus (Fisher Scientific) microscope slides. Following incubation at 60°C for 30 min, the tissues sections were deparaffinized and rehydrated using sequential washes (100% xylenes, 5 min × 2; 50% xylenes:50% ethanol, 5 min; 100% ethanol, 5 min × 2; 95% ethanol, 3 min; 75% ethanol, 3 min; 50% ethanol, 3 min; cold H 2 O, 5 min). Antigen retrieval was performed using sodium citrate buffer (pH 6.0) heated to 95°C in a pressure cooker for 35 min. Membrane solubilization and blocking was performed using SS-PBS (PBS plus 0.1% saponin, 10% goat serum). Primary antibodies were incubated overnight at 4°C in a humidified chamber. Primary antibodies used were as follows: mouse anti-ezrin (1:300; 3C12; Invitrogen), mouse anti-E-cadherin (1:400; BD Biosciences), rabbit anti-CD71 (1:50; Cell Signaling Technologies), rabbit anti-CD163 (1:50; M-96; Santa Cruz Biotechnology), and mouse anti-pTyr (1:250; 4G10 Invitrogen). Following washes in PBS, the slides were incubated with secondary antibodies in SS-PBS for 1 h at room temperature. Secondary antibodies used were goat anti-rabbit Alexa488 (1:1,000; Invitrogen) and goat anti-mouse Alexa555 (1:1,000; Invitrogen). Slides were further stained with DAPI (1 mg/mL), and coverslips were mounted using Dako Fluorescent Mounting reagent (Dako).
Ussing Chamber Analyses. Mice were killed by cervical dislocation, and the colon and small bowel were excised and placed into oxygenated Kreb's buffer (115 mM NaCl, 1.25 mM CaCl 2 , 1.2 mM MgCl 2 , 2.0 mM KH 2 PO 4 and 25 mM NaHCO 3 at pH 7.35) at 37°C. Small bowel sections were obtained proximal to the cecum, whereas large bowel sections were obtained proximal to the anus. Excised tissue were opened by dissection along the mesentery axis and mounted on 2.8 mm × 11.2 mm oblong sliders (P2304; Physiological Instruments) with the luminal side down. The sliders were loaded into a four-chamber Ussing chamber system (EM-CSYS-4; Physiological Instruments) that was precalibrated. Kreb's buffer was added to both chambers, whereas 10 mM glucose was added to the serosal side as an energy source and 10 mM mannitol was added to the luminal side to maintain osmotic balance. Agar-salt bridges were used to both monitor potential difference across the membrane and to apply the appropriate short-circuit current (I sc ) to maintain the potential difference at zero as controlled through an automated voltage clamp. The system is controlled through the Acquire and Analyze software (Physiological Systems), which modulates voltage and current controls remotely. The tissue was allowed to equilibrate for 15 min before I sc readings were taken. Whereas we were able to measure transepithelial electric resistance (TEER) in colonic epithelial tissues obtained from WT and PTPσ −/− mice (described above), we were not able to measure TEER in colonic Caco-2 cells following knockdown of PTPσ, because such knockdown disrupted the integrity of the epithelial monolayer.
Macromolecular Permeability. After the tissues had equilibrated in the Ussing chamber and baseline I sc readings were acquired, 10
M horseradish peroxidase (HRP) (Type VI; Sigma) was added to the luminal chambers to act as a probe for macromolecular permeability; 500-μL samples were taken from the serosal chambers at 30-min intervals for 2 h and replaced by 500 μL of fresh Kreb's buffer to maintain constant volume. A modified Worthington method was used to evaluate the enzymatic activity of the HRP in the serosal samples as described (4) . , and PTPσ +/+ littermates were fasted for 4 h and then administered 15 mg of fluorescein isothiocyanate (FITC)-dextran (molecular mass, 3,000-5,000 or 40,000 Da; Sigma) by orogastric gavage. Needle size and gavage volume used were determined according to weight of the mouse based on standard practices. After 4 h, the mice were killed by cervical dislocation and bled by cardiac puncture. Serum was isolated using centrifugation, and serum FITC levels were evaluated using fluorometry in a 96-well plate. littermates were treated with 3% dextran sodium sulfate (Sigma) in their drinking water ad libitum for 4 d. The mice were monitored daily for weight loss, stool consistency, rectal bleeding, and general health. On the fourth day, the mice were killed, and the small bowel and colon were excised and fixed using 4% wt/vol PFA in PBS. Transiently transfected FLAG tagged ezrin was precipitated from HEK293T cell lysate in a GST pull-down assay using the GST-PTPσ-D1(D1472A) substrate-trapping mutant in the presence or absence of PV. The untreated pull down (σD1-DA) demonstrated ezrin coprecipitation with the PTPσ-D1 domain, as shown by positive ezrin immunostaining by Western blot. Following PV treatment at 1 or 100 mM concentrations, this interaction is lost, because ezrin does not appear in the pull-down lysate. Pull down using GST-agarose alone was used as a negative control to ensure binding specificity. (B) Transiently transfected FLAG-tagged ezrin was immunoprecipitated from HEK293T cells and then incubated with the D1 domain of PTPσ in vitro for 30 min with or without the addition of PV. Thirty minutes of incubation with 1 or 100 mM PV showed no change in pTyr-staining intensity compared with initial levels, whereas the incubation without PV showed almost complete loss of pTyr. . Ezrin (EZR) weakly binds to E-cadherin, and this interaction is reduced in the Y353E mutant. WT or pTyr mutant FLAG-tagged EZR constructs were transiently cotransfected with mCherry-tagged E-cadherin into HEK293T cells. EZR was immunoprecipitated (IP) from cell lysates using anti-FLAG agarose. Bound proteins were eluted using 1× SDS sample buffer, separated by SDS/PAGE, and immunoblotted (IB) using anti-FLAG and anti-mCherry antibodies. (A) Immunoblot demonstrating co-IP of mCherry-E-cadherin with the FLAG-EZR. The negative control lane corresponds to a FLAG-tagged control protein (Nterminal fragment of villin) that does not interact with E-cadherin. (B) Quantitation of the mCherry-E-cadherin signal intensity for the immunoblot in A, demonstrating reduced binding for the Y353E-EZR mutant. Values were normalized to the amount of FLAG-EZR IP. Each phosphomutant is illustrated as a ratio relative to WT-EZR. All quantitation was conducted using ImageJ. Data are means ± SD (n = 4 experiments; *P < 0.0001; Student t test). Epidermal growth factor receptor pathway substrate 8 3
